Criteria for 5 years survival prognosis in patients with thymus tumors

Abstract

Thymoma is a rare tumor of mediastinum, which incidence is less than 1% of all oncological diseases, and 10-20% of primary mediastinum lesions. Current WHO classification (Masaoka staging and histological tumor type) does not allow to determine the necessity for additional methods of treatment and to predict the further development of disease. The developed individual prognostic system for disease progression probability assessment, based on certain criteria, is a simple and cheap prognostic method in patients with thymoma.

Keywords

• тимома
• опухоли вилочковой железы
• опухоли средостения
• рак тимуса